Recently, there is a growing body of evidence that the altered levels of neurotrophins and their receptors, particularly BDNF/TrkB system, are correlated with major depressive disorder (MDD) and AD (Autry, 2022; Kumari et al., 2023). Here, NTRK2 is linked to Alzheimer disease.